Latest Insider Transactions at Cara Therapeutics, Inc. (CARA)
This section provides a real-time view of insider transactions for Cara Therapeutics, Inc. (CARA). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of Cara Therapeutics, Inc. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of Cara Therapeutics, Inc.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Aug 01
2024
|
Christopher Posner PRESIDENT AND CEO |
SELL
Open market or private sale
|
Direct |
4,149
-2.35%
|
$0
$0.35 P/Share
|
|
Jun 04
2024
|
Jeffrey L. Ives |
BUY
Grant, award, or other acquisition
|
Direct |
150,647
+43.15%
|
-
|
|
Jun 04
2024
|
Lisa Von Moltke |
BUY
Grant, award, or other acquisition
|
Direct |
150,647
+45.15%
|
-
|
|
Jun 04
2024
|
Helen M Boudreau |
BUY
Grant, award, or other acquisition
|
Direct |
150,647
+50.0%
|
-
|
|
Jun 04
2024
|
Martin Vogelbaum |
BUY
Grant, award, or other acquisition
|
Direct |
301,295
+42.3%
|
-
|
|
Jun 04
2024
|
Susan Ph.D. Shiff |
BUY
Grant, award, or other acquisition
|
Direct |
150,647
+42.71%
|
-
|
|
May 02
2024
|
Christopher Posner PRESIDENT AND CEO |
SELL
Open market or private sale
|
Direct |
3,936
-2.18%
|
$0
$0.75 P/Share
|
|
Apr 05
2024
|
Scott Terrillion SEC'Y; CHIEF COMPLIANCE & G.C. |
SELL
Open market or private sale
|
Direct |
2,753
-3.03%
|
$0
$0.83 P/Share
|
|
Apr 05
2024
|
Joana Goncalves CHIEF MEDICAL OFFICER |
SELL
Open market or private sale
|
Direct |
2,753
-4.91%
|
$0
$0.83 P/Share
|
|
Feb 29
2024
|
Scott Terrillion SEC'Y; CHIEF COMPLIANCE & G.C. |
SELL
Open market or private sale
|
Direct |
3,293
-3.49%
|
$0
$0.89 P/Share
|
|
Feb 29
2024
|
Christopher Posner PRESIDENT AND CEO |
SELL
Open market or private sale
|
Direct |
5,834
-3.13%
|
$0
$0.89 P/Share
|
|
Feb 29
2024
|
Joana Goncalves CHIEF MEDICAL OFFICER |
SELL
Open market or private sale
|
Direct |
3,293
-5.54%
|
$0
$0.89 P/Share
|
|
Feb 08
2024
|
Christopher Posner PRESIDENT AND CEO |
SELL
Open market or private sale
|
Direct |
35,575
-16.03%
|
$0
$0.53 P/Share
|
|
Feb 01
2024
|
Joana Goncalves CHIEF MEDICAL OFFICER |
BUY
Grant, award, or other acquisition
|
Direct |
13,500
+16.73%
|
-
|
|
Feb 01
2024
|
Ryan D Maynard CHIEF FINANCIAL OFFICER |
BUY
Grant, award, or other acquisition
|
Direct |
13,500
+50.0%
|
-
|
|
Feb 01
2024
|
Scott Terrillion SEC'Y; CHIEF COMPLIANCE & G.C. |
BUY
Grant, award, or other acquisition
|
Direct |
13,500
+11.68%
|
-
|
|
Feb 01
2024
|
Christopher Posner PRESIDENT AND CEO |
SELL
Open market or private sale
|
Direct |
4,981
-2.2%
|
$0
$0.55 P/Share
|
|
Feb 01
2024
|
Christopher Posner PRESIDENT AND CEO |
BUY
Grant, award, or other acquisition
|
Direct |
62,500
+21.6%
|
-
|
|
Feb 01
2024
|
Frederique Ph.D. Menzaghi CHIEF SCIENTIFIC OFF,SVP-R&D |
BUY
Grant, award, or other acquisition
|
Direct |
13,500
+7.47%
|
-
|
|
Nov 02
2023
|
Christopher Posner PRESIDENT AND CEO |
SELL
Open market or private sale
|
Direct |
3,796
-2.26%
|
$3,796
$1.22 P/Share
|
|
Aug 03
2023
|
Christopher Posner PRESIDENT AND CEO |
SELL
Open market or private sale
|
Direct |
4,307
-2.5%
|
$12,921
$3.07 P/Share
|
|
Jun 23
2023
|
Joana Goncalves CHIEF MEDICAL OFFICER |
SELL
Open market or private sale
|
Direct |
2,723
-4.83%
|
$8,169
$3.51 P/Share
|
|
Jun 23
2023
|
Frederique Ph.D. Menzaghi CHIEF SCIENTIFIC OFF,SVP-R&D |
SELL
Open market or private sale
|
Direct |
2,993
-1.91%
|
$8,979
$3.51 P/Share
|
|
Jun 23
2023
|
Scott Terrillion SEC'Y; CHIEF COMPLIANCE & G.C. |
SELL
Open market or private sale
|
Direct |
2,483
-2.73%
|
$7,449
$3.51 P/Share
|
|
Jun 01
2023
|
Lisa Von Moltke |
BUY
Grant, award, or other acquisition
|
Direct |
32,362
+50.0%
|
-
|
|
Jun 01
2023
|
Martin Vogelbaum |
BUY
Grant, award, or other acquisition
|
Direct |
64,724
+37.1%
|
-
|
|
Jun 01
2023
|
Harrison M Bains Jr Director |
BUY
Grant, award, or other acquisition
|
Direct |
32,362
+36.04%
|
-
|
|
Jun 01
2023
|
Jeffrey L. Ives |
BUY
Grant, award, or other acquisition
|
Direct |
32,362
+40.35%
|
-
|
|
Jun 01
2023
|
Susan Ph.D. Shiff |
BUY
Grant, award, or other acquisition
|
Direct |
32,362
+38.62%
|
-
|
|
May 05
2023
|
Christopher Posner PRESIDENT AND CEO |
SELL
Open market or private sale
|
Direct |
3,869
-2.19%
|
$15,476
$4.4 P/Share
|
|
Apr 04
2023
|
Frederique Ph.D. Menzaghi CHIEF SCIENTIFIC OFF,SVP-R&D |
SELL
Open market or private sale
|
Direct |
2,733
-1.71%
|
$10,932
$4.91 P/Share
|
|
Apr 04
2023
|
Joana Goncalves CHIEF MEDICAL OFFICER |
SELL
Open market or private sale
|
Direct |
2,481
-4.21%
|
$9,924
$4.91 P/Share
|
|
Apr 04
2023
|
Scott Terrillion SEC'Y; CHIEF COMPLIANCE & G.C. |
SELL
Open market or private sale
|
Direct |
2,481
-2.65%
|
$9,924
$4.91 P/Share
|
|
Mar 03
2023
|
Joana Goncalves CHIEF MEDICAL OFFICER |
SELL
Open market or private sale
|
Direct |
6,221
-9.56%
|
$55,989
$9.71 P/Share
|
|
Mar 03
2023
|
Scott Terrillion SEC'Y; CHIEF COMPLIANCE & G.C. |
SELL
Open market or private sale
|
Direct |
6,256
-6.27%
|
$56,304
$9.71 P/Share
|
|
Mar 03
2023
|
Frederique Ph.D. Menzaghi CHIEF SCIENTIFIC OFF,SVP-R&D |
SELL
Open market or private sale
|
Direct |
6,802
-4.09%
|
$61,218
$9.71 P/Share
|
|
Mar 03
2023
|
Christopher Posner PRESIDENT AND CEO |
SELL
Open market or private sale
|
Direct |
5,987
-3.28%
|
$53,883
$9.71 P/Share
|
|
Feb 16
2023
|
Joana Goncalves CHIEF MEDICAL OFFICER |
SELL
Open market or private sale
|
Direct |
2,265
-3.36%
|
$22,650
$10.2 P/Share
|
|
Feb 08
2023
|
Ryan D Maynard CHIEF FINANCIAL OFFICER |
SELL
Open market or private sale
|
Direct |
5,488
-40.65%
|
$0
$0.53 P/Share
|
|
Feb 08
2023
|
Scott Terrillion SEC'Y; CHIEF COMPLIANCE & G.C. |
SELL
Open market or private sale
|
Direct |
7,770
-7.61%
|
$0
$0.53 P/Share
|
|
Feb 08
2023
|
Joana Goncalves CHIEF MEDICAL OFFICER |
SELL
Open market or private sale
|
Direct |
7,770
-11.57%
|
$0
$0.53 P/Share
|
|
Feb 02
2023
|
Christopher Posner PRESIDENT AND CEO |
SELL
Open market or private sale
|
Direct |
4,191
-2.25%
|
$46,101
$11.8 P/Share
|
|
Jan 17
2023
|
Joana Goncalves CHIEF MEDICAL OFFICER |
SELL
Open market or private sale
|
Direct |
2,265
-3.25%
|
$22,650
$10.81 P/Share
|
|
Dec 29
2022
|
Joana Goncalves CHIEF MEDICAL OFFICER |
SELL
Open market or private sale
|
Direct |
2,265
-3.15%
|
$22,650
$10.18 P/Share
|
|
Dec 21
2022
|
Scott Terrillion SEC'Y; CHIEF COMPLIANCE & G.C. |
SELL
Open market or private sale
|
Direct |
2,561
-2.5%
|
$28,171
$11.27 P/Share
|
|
Dec 21
2022
|
Joana Goncalves CHIEF MEDICAL OFFICER |
SELL
Open market or private sale
|
Direct |
2,992
-4.0%
|
$32,912
$11.27 P/Share
|
|
Dec 21
2022
|
Frederique Ph.D. Menzaghi CHIEF SCIENTIFIC OFF,SVP-R&D |
SELL
Open market or private sale
|
Direct |
3,506
-2.07%
|
$38,566
$11.27 P/Share
|
|
Nov 16
2022
|
Christopher Posner PRESIDENT AND CEO |
SELL
Open market or private sale
|
Direct |
14,470
-7.2%
|
$159,170
$11.13 P/Share
|
|
Sep 14
2022
|
Martin Vogelbaum |
SELL
Open market or private sale
|
Direct |
10,800
-19.36%
|
$108,000
$10.28 P/Share
|
|
Jul 15
2022
|
Jeffrey L. Ives |
SELL
Open market or private sale
|
Direct |
3,600
-18.87%
|
$32,400
$9.05 P/Share
|